Michael Ross Ascuitto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michael Ross Ascuitto has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Roberto de la Salud Bea
Department of Chemistry, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA
2 shared publications - Adam F. Petraglia
Department of Chemistry, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA
1 shared publication Dalia Guertin
Department of Family Medicine, Baton Rouge General Hospital, Baton Rouge, LA, USA
1 shared publicationKaycee Weaver
Department of Family Medicine, Baton Rouge General Hospital, Baton Rouge, LA, USA
1 shared publicationLaura Elena Luque de Johnson
Department of Biology, Rhodes College, 2000 North Parkway, Memphis, TN 38112, United States
1 shared publication- Quentin M. Buck
Department of Chemistry, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA
1 shared publication
Latest Publications
- 23 August 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 38 (6) , 834-836
Acute unilateral vision loss from central retinal artery occlusion associated with an atrial septal aneurysm and a patent foramen ovale: a case report
Background: Acute unilateral vision loss is an ophthalmological emergency. It can have multiple aetiologies, and physicians must be able to quickly determine the cause of the condition, as immediate intervention may prevent permanent vision loss. Acute unilateral vision loss has not previously been associated with a patent foramen ovale (PFO). Objective: We describe a patient who presented with painless sudden loss of vision in his left eye. He was diagnosed to have central retinal artery occlusion, likely from a paradoxical embolus associated with an atrial septal aneurysm containing a PFO. The patient underwent successful percutaneous closure of the PFO without complication. This report details the evaluation and differential diagnosis of acute unilateral vision loss. Additionally, the controversy of whether a PFO should be closed prophylactically for stroke prevention is discussed. Conclusion: Acute unilateral vision loss from central retinal artery occlusion may be caused by a paradoxical embolus originating from an atrial septal aneurysm with a PFO. This case should be considered in the controversy of whether prophylactic closure of a PFO could be beneficial for primary prevention of stroke.
- 23 August 2021
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 38 (6) , 834-836
Acute unilateral vision loss from central retinal artery occlusion associated with an atrial septal aneurysm and a patent foramen ovale: a case report
Background: Acute unilateral vision loss is an ophthalmological emergency. It can have multiple aetiologies, and physicians must be able to quickly determine the cause of the condition, as immediate intervention may prevent permanent vision loss. Acute unilateral vision loss has not previously been associated with a patent foramen ovale (PFO). Objective: We describe a patient who presented with painless sudden loss of vision in his left eye. He was diagnosed to have central retinal artery occlusion, likely from a paradoxical embolus associated with an atrial septal aneurysm containing a PFO. The patient underwent successful percutaneous closure of the PFO without complication. This report details the evaluation and differential diagnosis of acute unilateral vision loss. Additionally, the controversy of whether a PFO should be closed prophylactically for stroke prevention is discussed. Conclusion: Acute unilateral vision loss from central retinal artery occlusion may be caused by a paradoxical embolus originating from an atrial septal aneurysm with a PFO. This case should be considered in the controversy of whether prophylactic closure of a PFO could be beneficial for primary prevention of stroke.
- Open Access
- 28 June 2017
- Published by MDPI AG in Antibiotics
- Vol. 6 (3) , 13
Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides
Seven analogs of the natural, α-helix peptides IsCT1 and IsCT2—found in the venom of scorpion Opithancatus Madagascariensis—have been synthesized and tested to compare their antibacterial and hemolytic activity against natural peptides. In general, results show that increasing hydrophobicity by substituting positions 5 and 9 of the sequences with alanine, valine, and leucine, enhances antibacterial activity. However, this also increases hemolytic activity. The analog with an increased net positive charge from +1 to +3 produces moderate bacterial growth inhibition but also has high hemolytic activity. On the other hand, the analog with a negative net charge (−1) has low antibacterial properties but also no cytotoxicity under the tested conditions, a similar result was found for five of the seven studied analogs.
- 28 June 2017
- Published by MDPI AG in Antibiotics
- Vol. 6 (3) , 13
Open AccessAntibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides
Seven analogs of the natural, α-helix peptides IsCT1 and IsCT2—found in the venom of scorpion Opithancatus Madagascariensis—have been synthesized and tested to compare their antibacterial and hemolytic activity against natural peptides. In general, results show that increasing hydrophobicity by substituting positions 5 and 9 of the sequences with alanine, valine, and leucine, enhances antibacterial activity. However, this also increases hemolytic activity. The analog with an increased net positive charge from +1 to +3 produces moderate bacterial growth inhibition but also has high hemolytic activity. On the other hand, the analog with a negative net charge (−1) has low antibacterial properties but also no cytotoxicity under the tested conditions, a similar result was found for five of the seven studied analogs.